MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Dermatofibrosarcoma Protuberans

(UMLS:C0392784)

UMLS ID:: C0392784
MeSH ID:: D018223

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.450.565.590.350.320|C04.557.450.795.350.320

Synonym(s)

Dermatofibrosarcoma Protuberans

DFSP - Dermatofibrosarcoma protruberans

DFSP - dermatofibrosarcoma protuberans

Dermatofibroma protuberans

Dermatofibrosarcoma

Dermatofibrosarcoma protuberans

Dermatofibrosarcoma protuberans, NOS

Dermatofibrosarcoma, no ICD-O subtype

Dermatofibrosarcoma, no International Classification of Diseases for Oncology subtype

10.

dermatofibrosarcoma protuberans

11.

dermatofibrosarcoma; protuberans

12.

dermatofibrosarcomas protuberans

13.

protuberans; dermatofibrosarcoma

14.

soft tissue malignant neoplasm dermatofibrosarcoma protuberans

Associated Drug(s)

	Name	Number of Reports	Data Source
1	Imatinib Mesylate	FAERS: 7 Canada Vigilance: 1	Canada Vigilance US FAERS
2	Finasteride	FAERS: 1	US FAERS
3	Fingolimod Hydrochloride	FAERS: 1	US FAERS
4	Teriparatide	Canada Vigilance: 1	Canada Vigilance

Similar ADE(s)

	Name	Semantic Similarity
1	Chondrosarcoma	48.3%
2	synovial sarcoma	48.3%
3	Clear Cell Sarcoma of Soft Tissue	48.3%
4	Malignant Fibrous Histiocytoma	41.3%
5	leiomyosarcoma	40.3%
6	liposarcoma	40.3%
7	Alveolar Soft Part Sarcoma	40.3%
8	Osteosarcoma	39.4%
9	Carcinosarcoma	36.6%
10	Hemangiosarcoma	36.6%
11	lymphangiosarcoma	36.6%
12	Neurofibrosarcoma	35.4%
13	Phyllodes Tumor	33.2%
14	Desmoplastic Small Round Cell Tumor	33.2%
15	fibroma	31.9%
16	Fibromatosis	31.9%
17	Sarcoma, Myeloid	31.5%
18	Myxoma	31%
19	Neoplasms, Bone Tissue	31%
20	Chondroma	31%
21	Enchondroma	31%
22	Angiomyolipoma	30.7%
23	Giant Cell Tumor of Bone	28.9%
24	leukemia	28.8%
25	Neoplasms, Germ Cell and Embryonal	28.8%
26	Neoplasms, Glandular and Epithelial	28.8%
27	Germ Cell Cancer	28.8%
28	Sarcoma, Experimental	26.1%
29	Rhabdomyosarcoma	25.7%
30	Carcinoma 256, Walker	24.2%
31	Neuroectodermal Tumors	23.1%
32	Adenofibroma	23%
33	Fibroadenoma	23%
34	Fibromatosis, Aggressive	21.8%
35	Fibromatosis, Abdominal	21.8%
36	Histiocytic Disorders, Malignant	21.6%
37	Lipoma	20.4%
38	Myoma	20.4%
39	Angiolipoma	20.4%
40	Myelolipoma	20.4%
41	Smooth Muscle Tumor	20.4%
42	Sarcoma 180	20%
43	Neoplasms, Neuroepithelial	19.8%
44	Gliomatosis cerebri	19.8%
45	Osteoblastoma	19.3%
46	Osteoma	19.3%
47	Chondromatosis	19.3%
48	Mastocytosis	19.2%
49	Hamartoma	19.2%
50	Neoplasms, Hormone-Dependent	19.2%
51	Neoplasms, Multiple Primary	19.2%
52	Paraneoplastic Syndromes	19.2%
53	Precancerous Conditions	19.2%
54	Neoplasms, Second Primary	19.2%
55	Gastrointestinal Stromal Tumors	19%
56	Alveolar rhabdomyosarcoma	18.5%
57	Endometrial Stromal Sarcoma	18.3%
58	Lymphoma	17.4%
59	Sarcoma	16.9%
60	Meningioma	16.3%
61	melanoma	15.8%
62	Composite Lymphoma	15.4%
63	Adenoma	15.3%
64	Ameloblastoma	15.3%
65	Angiokeratoma	15.3%
66	Carcinoma	15.3%
67	Chordoma	15.3%
68	Hemangioma	15.3%
69	hemangiopericytoma	15.3%
70	Lymphangioma	15.3%
71	Mesenchymoma	15.3%
72	Nevus	15.3%
73	Teratoma	15.3%
74	Hepatoblastoma	15.3%
75	Mixed Tumor, Mullerian	15.3%
76	Germinoma	15.3%
77	Teratocarcinoma	15.3%
78	Angiofibroma	15.3%
79	Epithelioma	15.3%
80	Trophoblastic Neoplasms	15.2%
81	Leukemia, Experimental	15.1%
82	Lymphangioleiomyomatosis	14.7%
83	Mastocytoma	14.6%
84	Cyst	14.5%
85	Neoplastic Processes	14.5%
86	Neoplastic Syndromes, Hereditary	14.5%
87	Pregnancy Complications, Neoplastic	14.5%
88	Mastocytosis, Systemic	14.5%
89	Leukemia, Plasma Cell	14.5%
90	Neoplasms, Experimental	14.3%
91	Carcinoma, Ehrlich Tumor	13.9%
92	Dermoid Cyst	13.9%
93	Carcinoma, Lewis Lung	13.9%
94	Dupuytren Contracture	13.6%
95	Basal cell carcinoma	13.2%
96	Carcinoma, Papillary	13.2%
97	Squamous cell carcinoma	13.2%
98	Craniopharyngioma	13.2%
99	Cystadenoma	13.2%
100	Mesothelioma	13.2%
101	Neuroectodermal Tumor, Melanotic	13.2%
102	Neuroendocrine Tumors	13.2%
103	Carcinoma, Basal Cell	13.2%
104	Rhabdomyoma	12.9%
105	Leukemia, Radiation-Induced	12.8%
106	Fibrosarcoma	12.5%
107	Adenoma, Acidophil	11.9%
108	Ganglioneuroma	11.9%
109	Glioma	11.9%
110	Malignant Glioma	11.9%
111	Plasmacytoma	11.6%
112	Malignant histiocytosis	11.5%
113	Histiocytic sarcoma	11.5%
114	Neoplasms, Radiation-Induced	11.5%
115	Melanoma, Experimental	11.3%
116	Neoplasms, Fibrous Tissue	11.1%
117	Thymoma	11%
118	Multiple Endocrine Neoplasia	10.7%
119	Cystadenocarcinoma	10.7%
120	Mucoepidermoid Carcinoma	10.7%
121	Leukemia L1210	10.5%
122	Leukemia P388	10.5%
123	Acanthoma	10.5%
124	Medulloblastoma	10.1%
125	Carcinoid Tumor	10%
126	Neurilemmoma	10%
127	Hutchinson's Melanotic Freckle	10%
128	Melanoma, Amelanotic	10%
129	Choriocarcinoma	9.8%
130	Carcinoma, Lobular	9.8%
131	Abdominal Neoplasms	9.6%
132	Erythroplasia	9.6%
133	Follicular cyst	9.6%
134	Head and Neck Neoplasms	9.6%
135	Mucocele	9.6%
136	Pilonidal Cyst	9.6%
137	Soft Tissue Neoplasms	9.6%
138	Thoracic Neoplasms	9.6%
139	Thyroglossal Cyst	9.6%
140	Synovial Cyst	9.6%
141	Aberrant Crypt Foci	9.6%
142	Hodgkin Disease	9.2%
143	Lymphoma, Non-Hodgkin	9.2%
144	Paraneoplastic Encephalomyelitis	9%
145	Mammary Neoplasms, Experimental	8.9%
146	Adenocarcinoma	8.8%
147	Carcinoma in Situ	8.8%
148	Carcinoma, Transitional Cell	8.8%
149	Dysgerminoma	8.8%
150	Hemangioendothelioma	8.8%
151	Neuroma	8.8%
152	Papilloma	8.8%
153	Pseudomyxoma Peritonei	8.8%
154	Seminoma	8.8%
155	Papillomatosis	8.8%
156	Adenomatosis, Pulmonary	8.8%
157	Adenomatous Polyps	8.8%
158	Carcinoma, Large Cell	8.8%
159	Carcinoma, Small Cell	8.8%
160	Bowen's Disease	8.3%
161	Paraganglioma	8.3%
162	Dermatofibrosarcoma	8.3%
163	Dermatofibrosarcoma Protuberans	8.3%
164	Urticaria Pigmentosa	8.2%
165	Astrocytoma	8.1%
166	Ependymoma	8.1%
167	oligodendroglioma	8.1%
168	Ganglioglioma	8.1%
169	gliosarcoma	8.1%
170	Anaplastic astrocytoma	8.1%
171	Anaplastic Oligodendroglioma	8.1%
172	Nephroblastoma	8%
173	Tuberous Sclerosis	8%
174	Retinoblastoma	7.8%
175	Primary amyloidosis	7.7%
176	Digestive System Neoplasms	7.6%
177	Endocrine Gland Neoplasms	7.6%
178	Eye Neoplasms	7.6%
179	Nervous System Neoplasms	7.6%
180	Lymphomatoid Granulomatosis	7.5%
181	Bone neoplasms	7.3%
182	Leukoplakia	7.3%
183	Lymphocele	7.3%
184	Pancreatic Cyst	7.3%
185	Skin Neoplasms	7.3%
186	Hematologic Neoplasms	7.3%
187	Barrett Esophagus	7.2%
188	Breast Cyst	7.2%
189	Actinic keratosis	7.2%
190	Mediastinal Cyst	7.2%
191	Neoplasm Invasiveness	7.2%
192	Neoplasm Metastasis	7.2%
193	Neoplasm Recurrence, Local	7.2%
194	Parovarian Cyst	7.2%
195	Pericardial Cyst	7.2%
196	Splenic Neoplasms	7.2%
197	Thymic Cyst	7.2%
198	Carcinogenesis	7.2%
199	Myxoid cyst	7.2%
200	Metastasis	7.2%
201	Malignant Carcinoid Syndrome	7.1%
202	Leukemia, Myelomonocytic, Chronic	6.6%
203	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	6.6%
204	Mesoblastic Nephroma	6.4%
205	Basal Cell Nevus Syndrome	6.2%
206	Glioblastoma	6.1%
207	Neuroblastoma	6.1%
208	Glioblastoma Multiforme	6.1%
209	Hepatocellular Adenoma	5.9%
210	Pheochromocytoma	5.9%
211	Waldenstrom Macroglobulinemia	5.8%
212	Multiple Myeloma	5.8%
213	Corpus Luteum Cyst	5.7%
214	Ovarian Cysts	5.7%
215	Multiple Endocrine Neoplasia Type 1	5.7%
216	Adenoid Cystic Carcinoma	5.5%
217	Adenocarcinoma, Clear Cell	5.5%
218	Cholangiocarcinoma	5.5%
219	Cervical Intraepithelial Neoplasia	5.5%
220	Hemangioblastoma	5.5%
221	Lymphoma, Extranodal NK-T-Cell	5.5%
222	Sturge-Weber Syndrome	5.4%
223	Liver Neoplasms, Experimental	5.4%
224	Hemangioma, Cavernous	5.3%
225	Parathyroid Neoplasms	5.3%
226	Peritoneal Neoplasms	5.3%
227	Thyroid Neoplasm	5.3%
228	Thyroid carcinoma	5.3%
229	Leukemia, T-Cell	5.3%
230	Leukemia, B-Cell	5.3%
231	neurofibroma	5.3%
232	Lymphoma, Follicular	5.2%
233	T-Cell Lymphoma	5.2%
234	Mantle cell lymphoma	5.2%
235	Carcinoma, Pancreatic Ductal	5.2%
236	Ganglioneuroblastoma	5.2%
237	Retroperitoneal Neoplasms	5.1%
238	Hydatidiform Mole	5.1%
239	Prolactinoma	5.1%
240	Growth Hormone-Secreting Pituitary Adenoma	5.1%
241	Choledochal Cyst	4.9%
242	Carcinoid Heart Disease	4.8%
243	Peutz-Jeghers Syndrome	4.8%
244	Acoustic Neuroma	4.6%
245	Pancreatic Neoplasm	4.6%
246	Adenomatous Polyposis Coli	4.5%
247	granulosa cell tumor	4.4%
248	Carcinoma, Ovarian Epithelial	4.4%
249	Optic Nerve Glioma	4.2%
250	Tracheal Neoplasms	4.2%
251	Leukemia, Myeloid, Chronic-Phase	4.2%
252	Leukoplakia, Oral	4.1%
253	Paraneoplastic Cerebellar Degeneration	4%
254	Klatskin Tumor	3.9%
255	Mouth Neoplasms	3.9%
256	Central Nervous System Neoplasms	3.9%
257	Vascular Neoplasms	3.9%
258	Thymus Neoplasms	3.9%
259	Vipoma	3.9%
260	Genital Neoplasms, Female	3.9%
261	Pancreatic Pseudocyst	3.9%
262	Lymphatic Metastasis	3.8%
263	Neoplasms, Unknown Primary	3.8%
264	Leukemic Infiltration	3.8%
265	Breast Neoplasms, Male	3.8%
266	Neoplasm Micrometastasis	3.8%
267	Triple Negative Breast Neoplasms	3.8%
268	Esophageal Neoplasms	3.5%
269	insulinoma	3.5%
270	Limbic Encephalitis	3.5%
271	Nasopharyngeal carcinoma	3.4%
272	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	3.3%
273	Leukemia, Large Granular Lymphocytic	3.3%
274	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	3.3%
275	Lymphoma, T-Cell, Cutaneous	3.3%
276	Lymphoma, AIDS-Related	3.3%
277	Enteropathy-Associated T-Cell Lymphoma	3.3%
278	Primary Effusion Lymphoma	3.3%
279	Denys-Drash Syndrome	3.2%
280	Adrenocortical carcinoma	3.2%
281	Adrenal Gland Neoplasms	3.2%
282	Gastrointestinal Neoplasms	3.2%
283	Genital Neoplasms, Male	3.2%
284	Liver neoplasms	3.2%
285	Uveal Neoplasms	3.2%
286	Urologic Neoplasms	3.1%
287	Sebaceous Gland Neoplasms	3.1%
288	Spinal Neoplasms	3.1%
289	Bone Marrow Neoplasms	3.1%
290	Lambert-Eaton Myasthenic Syndrome	3.1%
291	Testicular Neoplasms	3.1%
292	Polycystic Ovary Syndrome	3%
293	Thyroid Nodule	3%
294	Leydig Cell Tumor	2.9%
295	Xeroderma Pigmentosum	2.9%
296	Gastrinoma	2.9%
297	Glucagonoma	2.9%
298	Renal Cell Carcinoma	2.8%
299	Papillary Renal Cell Carcinoma	2.8%
300	Opsoclonus-Myoclonus Syndrome	2.7%
301	Carcinoma, Endometrioid	2.6%
302	Myelitis, Transverse	2.4%
303	Burkitt Lymphoma	2.4%
304	Mycosis Fungoides	2.4%
305	Lymphomatoid Papulosis	2.4%
306	Plasmablastic lymphoma	2.4%
307	ovarian neoplasm	2.2%
308	Meningeal Neoplasms	2.2%
309	Nose Neoplasms	2.1%
310	Pituitary Adenoma	1.9%
311	Pituitary Neoplasms	1.9%
312	Ear Neoplasms	1.8%
313	Eyelid Neoplasms	1.8%
314	Lung Neoplasms	1.8%
315	Pleural Neoplasms	1.8%
316	Palatal Neoplasms	1.8%
317	Cell Transformation, Viral	1.8%
318	Brain Neoplasms	1.8%
319	Salivary Gland Neoplasms	1.8%
320	Spinal Cord Neoplasms	1.8%
321	Tongue Neoplasms	1.8%
322	Uterine Neoplasms	1.8%
323	Vaginal Neoplasms	1.8%
324	Vulvar Neoplasms	1.8%
325	Uterine Cancer	1.8%
326	Fallopian Tube Neoplasms	1.8%
327	Zollinger-Ellison syndrome	1.7%
328	Sezary Syndrome	1.7%
329	Pharyngeal Neoplasms	1.5%
330	Central Nervous System Cysts	1.5%
331	Bile Duct Neoplasms	1.5%
332	gallbladder neoplasm	1.5%
333	Intestinal Neoplasms	1.5%
334	Penile Neoplasms	1.5%
335	Prostatic Neoplasms	1.5%
336	Stomach Neoplasms	1.5%
337	Polycythemia Vera	1.5%
338	Meningeal Carcinomatosis	1.4%
339	Laryngeal neoplasm	1.3%
340	Bladder Neoplasm	1.3%
341	Kidney Neoplasm	1.3%
342	Ureteral Neoplasms	1.3%
343	Urethral Neoplasms	1.3%
344	Bronchial Neoplasms	1.1%
345	Multiple Pulmonary Nodules	1.1%
346	Supratentorial Neoplasms	1.1%
347	Endometrial Neoplasms	1.1%
348	Hypopharyngeal Neoplasms	0.9%
349	Pleural Effusion, Malignant	0.9%
350	Hypopharyngeal Cancer	0.9%
351	Parotid Neoplasms	0.9%
352	Prostatic Neoplasms, Castration-Resistant	0.9%
353	Nelson Syndrome	0.9%
354	Cecal Neoplasms	0.8%
355	Duodenal Neoplasms	0.8%
356	Brain Stem Neoplasms	0.8%
357	Nasopharyngeal Neoplasms	0.7%
358	Colorectal Neoplasms	0.7%
359	Tonsillar Neoplasms	0.7%
360	Cerebellar Neoplasms	0.7%
361	Paranasal Sinus Neoplasms	0.6%
362	Choroid Plexus Papilloma	0.6%
363	Radicular Cyst	0.6%
364	Appendiceal Neoplasms	0.6%
365	Colonic Neoplasms	0.6%
366	Rectal Neoplasms	0.6%
367	Maxillary Sinus Neoplasms	0.4%
368	Anus Neoplasms	0.4%
369	Sigmoid Neoplasms	0.4%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234